Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Heart chip beats toward better drug screening, personalized medicine

Reuters Health | Tue Apr 14, 2015 5:22pm EDT BY BEN GRUBER BERKELEY, CALIFORNIA – Bioengineers in California have developed a system that allows human heart cells to function outside the body, a development that could potentially prove a powerful tool  for drug development as well as pave the way toward personalizing treatments for patients with heart conditions. […]

Read More »

Pfizer Beams As Cancer Drug Efficacy Stops Trial Early and Analysts Predict Game Changer

4/15/2015 8:43:44 AM Pfizer Announces PALOMA-3 Trial For IBRANCE® (Palbociclib) Stopped Early Due To Efficacy Seen In Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy  Phase 3 Top-Line Results Show IBRANCE in Combination with Fulvestrant Meets Progression-Free Survival (PFS) Primary Endpoint NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced that […]

Read More »

Heart Attack Risk Jumps After Divorce

A new study shows that after a divorce people have an increased lifetime risk for heart attacks (myocardial infarction). Although previous studies have found that MIs occur more frequently in people who are divorced, this is the first study to prospectively examine the lifetime relationship between divorce and MI. In a paper published in Circulation: Cardiovascular […]

Read More »

Should The FDA Require CV Outcome Studies For Diabetes Drugs Before Approval?

As the waistline of Americans has increased, so has the incidence of Type 2 diabetes. Startling data from the Centers for Disease Control  shows that that prevalence of this disease, which is directly related to obesity, now exceeds 9% in the adult population. It was less than half that rate in 1996. Furthermore, there doesn’t […]

Read More »

Polio Vaccine Found Safe And Effective 60 Years Ago: What Would Salk Think Today?

It was 60 years ago yesterday that the nation heaved an enormous collective sigh of relief. The largest clinical trial for a vaccine in history had concluded, the data had been collected and analyzed, and the results were announced on April 12, 1955, coincidentally the ten-year anniversary of polio sufferer Franklin D. Roosevelt’s death: Jonas […]

Read More »

Changing Sick Care To Health Care With A Simple Blood Test

There’s a lot of talk these days about the use of genomics and proteomics to develop personalized clinical treatments and improve the quality of our lives.  At a high level, genomics is essentially the study of a person’s genome and the use of its genes.  Proteomics is the study of the full set of proteins […]

Read More »

Biogen MS Drug Results Are ‘Mildly Encouraging’ In Eye Disease Test

Results from using Biogen’s experimental nerve repair drug in a disease of the eye were “mildly encouraging,” experts say, keeping alive the hope that the medicine might work in multiple sclerosis. The results will be presented next week at the 67th Annual Meeting of the American Academy of Neurology (AAN) in Washington, DC. Forbes received […]

Read More »

Divorce Could Literally (Eventually) Break A Woman’s Heart, Says Study

It’s not news that divorce is stressful – stressful enough that past research has frequently documented poorer health among divorcees. But those with a previous divorce, particularly women, appear to have a higher risk of heart attack, found a study published in the journal Circulation today. Well established risk factors for coronary heart disease, the […]

Read More »

OMEICOS Therapeutics Raises EUR 6.2 Million in Series A to Advance Lead Candidate in Atrial Fibrillation

BERLIN–(BUSINESS WIRE)–OMEICOS Therapeutics, a biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation (AF), today announced that it has raised EUR 6.2 million in a Series A round. Participating in the round were Vesalius Biocapital II S.A. SICAR, acting as lead; a SMS Group Company; VC […]

Read More »

The Lancet Publishes The First Ever Successful Series of Clinical Heart Transplants From DCD Donors Using The TransMedics Organ Care System (OCS)

ANDOVER, Mass., April 15, 2015 /PRNewswire/ — TransMedics, the company that developed the Organ Care System (OCS™) announces that the groundbreaking series of adult heart transplants from a new potential source of donors completed in the latter half of 2014 has today been published in The Lancet. The OCS™ platform is the only medical device […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom